The COVID-19 pandemic is causing a major disruption to all aspects of our daily lives. Are you challenged with having to think “outside of the box” to create a safer environment for your participants and employees? Are you feeling the pandemic’s impact on your funding and budgets? During this webinar, you will learn how to identify drug testing strategies that will address both the safety and cost-effectiveness obstacles you face during this “new normal.” You’ll also hear examples of what other drug courts have done to mitigate risk and/or reduce operating costs.
At the end of this webinar you will be able to:
- Describe a systematic approach to determine which airborne infection procedures should be prioritized for their individual situation
- Better understand the safety obstacles facing drug testing and possible solutions that will mitigate risk
- Apply tactics that will reduce testing costs but still provide positive participant outcomes
- Consider solutions from multiple drug courts that have adopted new processes to mitigate risk and reduce costs
Andrew Cummings, Executive Director, Advanced Outcomes Consulting Group
S. Tim Prewett, Administrator of Superior Court, Douglas County Judicial Circuit
This webinar is hosted by the National Association of Drug Court Professionals (NADCP) and sponsored by Thermo Fisher Scientific, was recorded on September 10, 2020.